Friday, February 10, 2012
"Concise industry news from the US pharmaceutical industry..."
Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Blog
Spencer Green
Chairman, GDS International
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?25 May 2011
White Papers
Focus Area: Drug Discovery
1 of 4
Previous |
Next
Drug Discovery
Breaking New Ground
Sean Harper tells NGP why he is excited about potential new treatments for osteoporosis, why animal models aren't always useful in developing drugs for humans, and why the pharmaceutical industry is on the brink of major change.
No Comments
Beyond Blockbusters
Uncovering specialized therapies worthy of investment, by Mike Burke.
No Comments
It’s All in the Genes
Tailoring therapies could improve the way patients respond to treatments, which is why this has become a key part of Lilly’s strategy.
No Comments
CROs Offer Efficient Outsourcing
By Dave Champagne, VP and General Manager, Informatics, Thermo Fisher Scientific
No Comments
The Latest on Live Cell Imaging
With Laurence Pelletier of Mount Sinai Hospital and Cathy Owen of Nanopoint
No Comments
1 of 4
Previous |
Next
Source: www.ngpharma.com© 2012 GDS Publishing Ltd. All rights reserved.